ARCHIVES

NSABP Trial Finds Raloxifene Equivalent To Tamoxifen For Cancer Risk Reduction

This article is from The Cancer Letter archive.

Vol. 29 No. 4 | April 28, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Codifies Rules For Expanded Access, Charging For Drugs In Clinical Trials.

December 22, 2006

Conversation With The Cancer Letter: PanCAN CEO Denies Bill Would Undermine NCI’s Role in Directing and Funding Research

August 3, 2012

Fish Oil May Help Prevent Weight Loss In Cancer Patients

September 26, 2003

Avon Awards $30M To 13 Organizations

September 27, 2002

Preliminary Study Results Show DES In Utero Exposure May Not Be Threat Originally Feared

February 17, 1978

CMX001 Reduces Adenovirus Progression and Viremia

August 30, 2013